Skip to main content

Table 1 Clinical Characteristics of COVID-19 Patients with and Without Influenza IgM positive

From: Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China

Study Population

With Influenza IgM positive (n = 73)

Without Influenza IgM positive (n = 67)

Total (n = 140)

P value

Demographic

 Gender, Male

39 (53.4)

37 (55.2)

76 (54.3)

0.8310

 Age, media (IQR), yrs

62.0 (47.0, 70.0)

66.0 (55.0, 70.0)

65.0 (48.5, 70.0)

0.1118

Comorbidities

 Hypertension

32/70 (45.7)

30/67 (44.8)

62/137 (45.3)

0.9122

 Diabetes

12/72 (16.7)

10/67 (14.9)

22/139 (15.8)

0.7787

 Chronic respiratory disease

5/72 (6.9)

5/67 (7.5)

10/139 (7.2)

0.9060

 Cardiovascular disease

5/72 (6.9)

3/67 (4.5)

8/139 (5.8)

0.5301

 Malignancy

3/72 (4.2)

3/67 (4.5)

6/139 (4.3)

0.9282

 Chronic kidney disease

2/72 (2.8)

1/67 (1.5)

3/139 (2.2)

0.5983

Signs and symptoms

 Fever

55 (75.3)

53 (79.1)

108 (77.1)

0.5964

 Highest temperature, °C

38.5 (38.0, 39.0)

38.7 (38.2, 39.0)

38.5 (38.0, 39.0)

0.1274

 Chills

13 (17.8)

19 (28.4)

32 (22.9)

0.1375

 Cough

41/72 (56.9)

44/67 (65.7)

85/139 (61.2)

0.2915

 Productive cough

20/72 (27.8)

25/67 (37.3)

45/139 (32.4)

0.2299

 Chest pain/Chest congestion

19/72 (26.4)

13/67 (19.4)

32/139 (23.0)

0.3283

 Dyspnea

21/72 (29.2)

29/67 (43.3)

50/139 (36.0)

0.0831

 Diarrhea

18 (24.7)

25 (37.3)

43 (30.7)

0.1049

 Fatigue or myalgia

24/72 (33.3)

34/67 (50.7)

58/139 (41.7)

0.0375

Laboratory findings, median (IQR)

 White blood cells, × 109/mL

5.7 (4.2, 6.8)

5.7 (4.6, 7.9)

5.7 (4.4, 7.2)

0.3226

 Neutrophils, × 109/mL

3.9 (2.5, 4.8)

4.0 (2.6, 5.9)

3.9 (2.5, 5.3)

0.3600

 Lymphocytes, ×109/mL

1.2 (0.9, 1.6)

1.1 (0.8, 1.5)

1.1 (0.8, 1.5)

0.3826

 Lymphocytes< 0.8 × 109/mL

18/73 (24.7)

18/66 (27.3)

36/139 (25.9)

0.7252

 Red blood cells, × 1012/mL

4.1 (3.6, 4.6)

4.0 (3.7, 4.4)

4.0 (3.7, 4.5)

0.4502

 Platelets, ×109/ mL

230.0 (173.0, 292.0)

253.0 (169.0, 340.0)

235.0 (169.0, 312.0)

0.3622

 Platelets< 100 × 109/mL

5/73 (6.8)

6/66 (9.1)

11/139 (7.9)

0.6249

 Hemoglobin, g/L

122.0 (114.0, 137.0)

125.5 (113.0, 137.0)

123.0 (113.0, 137.0)

0.9143

 ALT, U/L

23.0 (17.0, 40.0)

22.5 (15.0, 41.0)

23.0 (16.0, 41.0)

0.7373

 AST, U/L

26.0 (19.0, 37.0)

30.0 (19.0, 41.0)

28.0 (19.0, 39.0)

0.3370

 Albumin, g/L

36.1 (32.2, 38.3)

35.0 (31.4, 37.1)

35.2 (31.7, 38.1)

0.2945

 Creatinine, μmol/L

70.0 (60.0, 89.5)

70.0 (59.0, 87.0)

70.0 (59.0, 89.0)

0.8596

 LDH, U/L

268.5 (204.0, 329.5)

287.0 (235.0, 351.0)

281.0 (212.0, 334.0)

0.2419

 LDH > 245 U/L

44/72 (61.1)

47/65 (72.3)

91/137 (66.4)

0.1658

 Troponin> 15.6 pg/mL, No (%)

7/51 (13.7)

12/56 (21.4)

19/107 (17.8)

0.2977

 NT-proBNP, pg/mL

140.0 (60.0, 334.0)

157.0 (64.0, 459.0)

151.0 (63.0, 411.0)

0.2883

 NT-proBNP≥247 pg/mL, No (%)

29/57 (50.9)

35/58 (60.3)

64/115 (55.7)

0.3069

 CRP, mg/L

21.3 (4.1, 49.2)

34.7 (9.1, 73.4)

27.2 (6.1, 69.8)

0.1281

 CRP ≥ 1 mg/L, No (%)

57/61 (93.4)

47/49 (95.9)

104/110 (94.5)

0.5651

 IL-6, pg/mL

9.8 (4.2, 21.1)

6.8 (3.6, 23.2)

9.4 (3.9, 23.2)

0.5603

 IL-6 ≥ 7 pg/mL, No (%)

25/42 (59.5)

15/35 (42.9)

40/77 (51.9)

0.1450

 Ferritin, μg/L

522.1 (320.5, 729.0)

630.5 (310.2, 1519.9)

562.6 (320.5, 986.5)

0.0964

 Ferritin> 150 μg/L, No (%)

39/43 (90.7)

33/35 (94.3)

72/78 (92.3)

0.5495

 PT, s

13.7 (13.2, 14.3)

13.8 (13.4, 14.2)

13.8 (13.3, 14.3)

0.9762

 APTT, s

39.6 (35.8, 42.0)

39.5 (37.8, 45.8)

39.6 (36.6, 44.3)

0.0243

 APTT> 42 s, No (%)

17/72 (23.6)

28/64 (43.8)

45/136 (33.1)

0.0127

 FIB, g/L

4.9 (3.9, 6.0)

5.3 (4.3, 6.2)

5.0 (4.1, 6.1)

0.2374

 D-Dimer, μg/mL

0.7 (0.5, 1.7)

1.2 (0.5, 2.1)

1.0 (0.5, 2.0)

0.2371

 D-Dimer≥0.5 μg/mL, No (%)

53/73 (72.6)

45/64 (70.3)

98/137 (71.5)

0.7669

  1. Note. Data are presented as n (%) or median (IQR, interquartile range) for each parameter. P values were calculated by chi-square test, Fisher’s exact test, or Mann-Whitney U test, where appropriate
  2. Abbreviations IQR interquartile range, ALT alanine aminotransferase, AST aspartate aminotransferase, LDH lactic Acid dehydrogenase, CRP C-reactive protein, IL-6 interleukin-6, PT prothrombintime, APTT activated partial thromboplastin time, FIB fibrinogen